Categories AlphaGraphs, Earnings, Technology

Earnings: Apple (AAPL) Q4 revenue jumps 29% on strong iPhone sales but misses estimates

Apple Inc. (NASDAQ: AAPL) on Thursday reported strong revenue and earnings growth for the fourth quarter of 2021, driven by impressive sales of iPhone, the company’s flagship product that accounts for nearly half of its sales, and continued expansion of the services business. The top line missed analysts’ forecasts, while earnings matched.

Apple Q4 2021 earnings infographic

The Cupertino-based gadget giant’s fourth-quarter sales increased 29% from last year to $83.4 billion, mainly reflecting a 47% surge in the sales of iPhone and steady growth of its services business. The top-line missed the consensus estimates.

During the September quarter, net profit moved up to $20.55 billion or $1.24 per share from $12.67 billion or $0.73 per share in the fourth quarter of 2020. It was in line with Wall Street’s expectations.

Apple iPhone quarterly revenue performance

“This year we launched our most powerful products ever, from M1-powered Macs to an iPhone 13 lineup that is setting a new standard for performance and empowering our customers to create and connect in new ways,” said Apple’s CEO Tim Cook.

Read management/analysts’ comments on Apple’s Q4 report

Apple’s stock has gained about 16% so far this year and is currently trading close to last month’s peak. It declined on Thursday evening following the announcement, after closing the regular session higher.

Prior Performance

  • Apple Q3 2021 earnings infographic


Stocks you may like:

Apple (AAPL) Stock

Microsoft (MSFT) Stock

Alphabet (GOOGL) Stock

International Business Machines Corp. (IBM) Stock


Most Popular

HP Inc. (HPQ) stock research summary | Q3 2021

HP Inc has shown a strong performance in Q4 2021. In spite of remote working, HP has shown a strong demand for PC and printer. The company has beat Zacks

VMware Inc. (VMW) stock research summary | Q3 2021

In this era of digital transformation, the technology industry is seeing a rapid influx of innovative products and solutions that help businesses adapt to the fast-changing and complex environment. VMware

IPO Alert: Cancer drug company Nuvectis Pharma set for $30-million IPO

After months of hectic activity, the IPO market experienced a lull in the Thanksgiving week, but it is still headed for a record year though the rush led by the

Add Comment
Viewing Highlight